Clinical Trial Update: Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating goserelin to prevent chemotherapy-induced ovarian failure in premenopausal lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ovarian Failure
• Premature Ovarian Failure in the Context of Chemotherapy-induced Ovarian Failure in Premenopausal Lymphoma Patients

Drugs mentioned

• Goserelin (Goserelin)

Snippet

Sponsor: Beni-Suef University | Conditions: Premature Ovarian Failure | Phase 2 | Status: UNKNOWN